These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 23703062)

  • 1. [A novel missense mutation in the alpha-sarcoglycan gene in a Spanish family with muscular dystrophy].
    Pinel-González A; Montero-Escribano P; Aladro Y; Gil-Fournier B; Ramiro-León S
    Rev Neurol; 2013 Jun; 56(11):590-1. PubMed ID: 23703062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcolemmal alpha and gamma sarcoglycan protein deficiencies in Turkish siblings with a novel missense mutation in the alpha sarcoglycan gene.
    Diniz G; Tosun Yildirim H; Akinci G; Hazan F; Ozturk A; Yararbas K; Tukun A
    Pediatr Neurol; 2014 Jun; 50(6):640-7. PubMed ID: 24742800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first case of primary alpha-sarcoglycanopathy identified in Albania, in two siblings with homozygous alpha-sarcoglycan mutation.
    Babameto-Laku A; Tabaku M; Tashko V; Cikuli M; Mokini V
    Genet Couns; 2011; 22(4):377-83. PubMed ID: 22303798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mutation in alpha sarcoglycan gene in an Iranian family with limb girdle muscular dystrophy 2D.
    Mojbafan M; Nilipour Y; Tonekaboni SH; Tavakkoly-Bazzaz J; Zeinali S
    Neurol Res; 2016 Mar; 38(3):220-3. PubMed ID: 27093116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new mutation of the SCGA gene is the cause of a late onset mild phenotype limb girdle muscular dystrophy type 2D with axial involvement.
    Gonzalez-Quereda L; Gallardo E; Töpf A; Alonso-Jimenez A; Straub V; Rodriguez MJ; Lleixa C; Illa I; Gallano P; Diaz-Manera J
    Neuromuscul Disord; 2018 Aug; 28(8):633-638. PubMed ID: 30007747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Milder forms of α-sarcoglicanopathies diagnosed in adulthood by NGS analysis.
    Cantero D; Hernández-Laín A; Martínez JFG; Pérez MR; Ruano Y; Lleixà C; Gallardo E; Domínguez-González C
    J Neurol Sci; 2018 Nov; 394():63-67. PubMed ID: 30218921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramyocardial Fat in Family With Limb-Girdle Muscular Dystrophy Type 2E Cardiomyopathy and Sudden Cardiac Death.
    Pashun RA; Azari BM; Achar A; Gruber D; Epstein LM; Geraci AP; Saba SG
    Circ Cardiovasc Imaging; 2020 Jul; 13(7):e010104. PubMed ID: 32635746
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta-sarcoglycanopathy (LGMD 2E) in a Spanish family.
    Rivas E; Teijeira S; dos Santos MR; Porrit I; Leturcq F; Fernandez JM; Navarro C
    Acta Myol; 2004 Dec; 23(3):159-62. PubMed ID: 15938574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute ischemic stroke in gamma-sarcoglycanopathy.
    Fayssoil A; Drouet T; Luis D; Orlikowski D; Alamowitch S; Annane D
    Presse Med; 2013 Apr; 42(4 Pt 1):484-6. PubMed ID: 23040950
    [No Abstract]   [Full Text] [Related]  

  • 10. Probable high prevalence of limb-girdle muscular dystrophy type 2D in Taiwan.
    Liang WC; Chou PC; Hung CC; Su YN; Kan TM; Chen WZ; Hayashi YK; Nishino I; Jong YJ
    J Neurol Sci; 2016 Mar; 362():304-8. PubMed ID: 26944168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Puerto Rican founder mutation G787A in the SGCG gene: a case report of 2 siblings with LGMD 2C.
    DiCapua D; Patwa H
    J Clin Neuromuscul Dis; 2014 Mar; 15(3):105-7. PubMed ID: 24534832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling the degradative route of the V247M α-sarcoglycan mutant responsible for LGMD-2D.
    Bianchini E; Fanin M; Mamchaoui K; Betto R; Sandonà D
    Hum Mol Genet; 2014 Jul; 23(14):3746-58. PubMed ID: 24565866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced therapeutic approaches in sarcoglycanopathies.
    Scano M; Benetollo A; Dalla Barba F; Sandonà D
    Curr Opin Pharmacol; 2024 Jun; 76():102459. PubMed ID: 38713975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI in sarcoglycanopathies: a large international cohort study.
    Tasca G; Monforte M; Díaz-Manera J; Brisca G; Semplicini C; D'Amico A; Fattori F; Pichiecchio A; Berardinelli A; Maggi L; Maccagnano E; Løkken N; Marini-Bettolo C; Munell F; Sanchez A; Alshaikh N; Voermans NC; Dastgir J; Vlodavets D; Haberlová J; Magnano G; Walter MC; Quijano-Roy S; Carlier RY; van Engelen BGM; Vissing J; Straub V; Bönnemann CG; Mercuri E; Muntoni F; Pegoraro E; Bertini E; Udd B; Ricci E; Bruno C
    J Neurol Neurosurg Psychiatry; 2018 Jan; 89(1):72-77. PubMed ID: 28889091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rescue of sarcoglycan mutations by inhibition of endoplasmic reticulum quality control is associated with minimal structural modifications.
    Soheili T; Gicquel E; Poupiot J; N'Guyen L; Le Roy F; Bartoli M; Richard I
    Hum Mutat; 2012 Feb; 33(2):429-39. PubMed ID: 22095924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an intragenic deletion in the SGCB gene through a re-evaluation of negative next generation sequencing results.
    Giugliano T; Fanin M; Savarese M; Piluso G; Angelini C; Nigro V
    Neuromuscul Disord; 2016 Jun; 26(6):367-9. PubMed ID: 27108072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myoglobinuria as first clinical sign of a primary alpha-sarcoglycanopathy.
    Ceravolo F; Messina S; Rodolico C; Strisciuglio P; Concolino D
    Eur J Pediatr; 2014 Feb; 173(2):239-42. PubMed ID: 23989969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LGMD2D syndrome: the importance of clinical and molecular genetics in patient and family management. Case Report.
    Al-Harbi KM; Abdallah AM
    Neuro Endocrinol Lett; 2016 Sep; 37(4):277-281. PubMed ID: 27857043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological and genetic features of patients with limb girdle muscular dystrophy type 2C.
    Dınız G; Hazan F; Yildirim HT; Unalp A; Polat M; Serdaroğlu G; Güzel O; Bağ O; Seçıl Y; Ozgönül F; Türe S; Akhan G; Tükün A
    Turk Patoloji Derg; 2014; 30(2):111-7. PubMed ID: 24638197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heart involvement in sarcoglycanopathies].
    Fayssoil A; Nardi O; Orlikowski D; Annane D
    Rev Neurol (Paris); 2012 Nov; 168(11):779-82. PubMed ID: 22405990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.